Metabolic syndrome: A disease of the brain

Open Nutraceuticals Journal

Volumn 4, Issue , 2011, Pages 107-118

  Pella, Daniel ^a   Otsuka, Kuniaki ^b   Singh, R B ^c  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c HALBERG HOSPITAL AND RESEARCH INSTITUTE   (India)

Author keywords

Brain development; Brain disease; Brain heart connection; Diet; Glucose intolerance; Insulin resistance; n 3 fatty acids; Nutrition

Indexed keywords

ACETYLCHOLINE; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOHYDRATE; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; LINOLEIC ACID; MEMBRANE PHOSPHOLIPID; MESSENGER RNA; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SEROTONIN; SPIRONOLACTONE; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; UNINDEXED DRUG;

ACETYLCHOLINE RELEASE; BRAIN DISEASE; BRAIN LEVEL; BREATHING EXERCISE; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ESSENTIAL FATTY ACID DEFICIENCY; HEART FAILURE; HEART RATE VARIABILITY; HIPPOCAMPUS; HUMAN; HYPERINSULINEMIA; HYPERPHAGIA; HYPOTHALAMUS FUNCTION DISORDER; HYPOTHALAMUS LESION; INFLAMMATION; INSULIN RESISTANCE; KINESIOTHERAPY; MEDITATION; MEDLINE; MENTAL STRESS; METABOLIC SYNDROME X; NERVE INJURY; NEUROPATHY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET DISEASE; PARASYMPATHETIC TONE; PATHOGENESIS; PERSONALITY; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; SYMPATHETIC TONE; SYSTEMATIC REVIEW; ZONA INCERTA;

ANIMALIA; RATTUS;

EID: 79960031683     PISSN: None     EISSN: 18763960     Source Type: Journal    
DOI: 10.2174/1876396001104010107     Document Type: Review

References (158)

1. Sachs JD and Commission on Macroeconomic and Health. A Race Against Time, The Challenge of Cardiovascular Disease in Developing Economies, The Earth Institute, Columbia University, New York, 2004.
2. Joint WHO/FAO Expert Consultation. Diet, Nutrition and the Prevention of Chronic Diseases, WHO, Geneva, WHO Technical Report Series, 916, 2003.
3. WHO Study Group. Diet, Nutrition and Prevention of Chronic Diseases, WHO, Geneva, 1990.
4. Simopoulos AP. Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. World Rev Nutr Diet 2003; 92:1-22.
5. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X):relation to reduced fetal growth. Diabetologia 1993; 36: 62-5.
6. Singh RB, Pella D, Otsuka K. Can brain dysfunction be a predisposing factor in metabolic syndrome? Biomed Pharmacother 2004; 58: 52-68.
7. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002; 18: 430-8.
8. Singh RB, Tomlinson B, Thomas N, Sharma R. Coronary artery disease and coronary risk factors: the South Asian paradox. J Nutr Environ Med 2001; 11: 43-51.
9. Pella D, Thomas N, Tomlinson B, Singh RB. Prevention of coronary artery disease: the south Asian paradox. Lancet 2003; 361: 79.
10. Pella D, Singh RB, Otsuka K, Chiang CE, Joshi SR. Nutritional predictors and modulators of metabolic syndrome. J Nutr Environ Med 2004; 14: 3-16.
11. Singh RB, Beegom R, Mehta AS, et al. Social class and coronary risk factors and undernutrition: a double burden of diseases among women in five Indian cities. Int J Cardiol 1999; 353: 154-65.
12. Singh RB, Vargova V, Mechirova V, Pella D. Acute Coronary Syndrome: A Progression of Pre-Metabolic Syndrome. World Heart J 2009; 1: 307-8.
13. Simopolous AP. Genetic variation and dietary response: nutrigenetics/nutrigenomics. Asia Pac J Clin Nutr 2002; 11: S117-28.
14. Singh RB, Cornelissen G, Weydahl A, et al. Circadian heart rate and blood pressure variability considered for research and patient care. Int J Cardiol 2003; 87: 9-28.
15. Singh RB, Weydahl K, Otsuka K, et al. Can nutrition influence heart rate and blood pressure variability. Biomed Pharmacother 2001, 55: 7-18.
16. th International Conference on Nutrition and Fitness. Athens, May 2000, New York, NY, Karger, 2001 (World Review of Nutrition and Dietetics, Vol 89).
17. Dubnov Gal, Pella D, Singh RB. The effect of an alpha-linolenic acid rich diet on the circadian rhythm of cardiac events. World Heart J 2008; 1: 49-56.
18. Singh RB, De Meester F, Pella D, Basu TK, Watson R. Globalization of dietary wild foods protect against cardiovascular disease and all cause mortalities? A Scientific statement from the International College of Cardiology, Columbus Paradigm Institute and the International College of Nutrition. Open Nutra J 2009; 2: 42-5.
19. Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-4.
20. Jovinge S, Hamsten A, Tomvall P, et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 1998; 47: 113-7.
21. Kumar SG, Das UN, Kumar KV, Tan BKH, Das NP. Effects of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutr Res 1992; 12: 815-20.
22. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-8.
23. Venters HD, Dantzer R, Kelly KW, et al. A new concept in neurodegeneration: TNF-alpha is a silencer of survival signals. Trends Neurosci 2000; 23: 175-80.
24. Venters HD, Tang Q, Liu Q, et al. A new mechanism of neurodegeneration:proinflammatory cytokines inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999; 96: 9879-84.
25. Lauritzen I, Blondeau N, Heueaux C, et al. Polyumsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784-8.
26. Axen KV, Li X, Fung K, Sclafani A. The VMH-dietary obese rat: a new model of noninsulin dependent diabetes mellitus. Am J Physiol 1994; 266(3 pt 2): R9210-15.
27. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic -lesioned rats. Brain Res 1999; 816: 38-41.
28. Dube MG, Kalra PS, Crowlwy WR, Kalra SP. Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 1995; 690: 275-81.
29. Takahashi A, Ishimaru H, Ikarashi Y, Maruyama Y. Aspects of hypothalamic neuronal systems in VMH lesion induced obese rats. J Auto Nerv Syst 1994; 48: 213-8.
30. Ohtani N, Ohta M, Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 1997; 69: 1622-6.
31. Funahashi T, Shimomura I, Hiraoka H, et al. Enhanced expression of rat obese (ob)gene in adipose tissues of ventromedial hypothalamus (VMH) lesioned rats. Biochem Biophys Res Commun 1995; 211: 469-73.
32. Williams G, Gill JS, Lee YC, et al. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 1989; 38: 321-5.
33. Katafuchi T, Okada E, Take S, Hori T. The biphasic changes in splenic natural killer cell activity following ventromedial hypothalamic lesions in rats. Brain Res 1994; 652: 164-9.
34. Hori T, Katafuchi T, Take S, Shimizu N. Neuroimmunomodulatory actions of hypothalamic interferon-alpha. Neuroimmunomodulation 1998; 5: 172-6.
35. Tanebe K, Nishijo H, Muraguchi A, Ono T. Effects of chronic stress on hypothalamic interleukin-1beta, interleukin-2, and gonadotrophin-releasing hormone gene expression in ovarectomized rats. J Neuroendocrinol 2000; 12: 13-7.
36. Katafuchi T, Motomura K, Baba S, Ota K, Hori T. Differential effects of tumor necrosis factor-alpha and beta on rat ventromedial hypothalamus neurons in vitro. Am J Physiol 1997; 272(6 pt 2): R1966-71.
37. Bruning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-3.
38. Wan Q, Xiong ZG, Man HY, et al. Recruitment of functional GABAa receptors to postsynaptic domains by insulin. Nature 1997; 388: 686.
39. Hill JM, Lesniak MA, Pert CB, Roth J. Autoradiographic localization of insulin receptors in:prominence in alfactory and limbic areas. Neuroscience 1986; 17: 1127-30.
40. Abott MA, Wells DG, Fallon JR. The insulin receptor tyrokinase substrate p58/53 and the insulin receptor components of CNS synapses. J Neurosci 1999; 19: 7300-6.
41. Sahu A, Dube MG, Phelps CP, et al. Insulin and insulin like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 1995; 136: 5718-22.
42. Hajnal A, Pothos EN, Lenard L, Hoebel BG. Effects of feeding and insulin on extracellular acetylecholine in the amygdala of freely moving rats. Brain Res 1998; 785: 41-4.
43. Dourmap N, Clero E, Costentin J. Involvement of cholynergic neurons in the release of dopamine elicited by stimulation muopioid receptors in striatum. Brain Res 1997; 749: 295-9.
44. Wang GJ, Volkov ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001; 357: 354-57.
45. Borovikova LV, Ivanova S, Zhang M, et al. Vagal nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
46. Salem N Jr, Wegher B, Mena P, Uauy R. Arachidonic and docosahaexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 1996; 93: 49-53.
47. Farquharson J, Jamieson EC, Abbasi KA, et al. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 1995; 72: 198-203.
48. Yu N, Martin JL, Stella N, Magistratti PJ. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc Natl Acad Sci USA 1993; 90: 4042-6.
49. Ragozzino ME, Unick KE, Gold PE. Hippocampal acetylecholine release during memory testing in rats:augmentation by glucose. Prog Natl Acad Sci USA 1996; 93: 4693-8.
50. Minami M, Kimura S, Endo T, et al. Dietary docosahexaenoic acid increases cerebral acetylecholine levels and improves passive avoidance-performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997; 58: 1123-8.
51. Hersi AI, Kitaichi K, Srivastav LK, Gaudreau P, Quirion R. Dopamine D-5 receptor modulates hippocampal acetylecholine release. Brain Res Mol Brain Res 2000; 76: 336-40.
52. Das UN. Possible beneficial actions of glucose, insulin-potassium regimen in acute myocardial infarction and inflammatory conditions:a hypothesis. Diabetologia 2000; 43: 1081-6.
53. Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells in vitro: a specific vascular action of insulin. Circulation 2000; 101: 676-80.
54. Satomi N, Sakurai A, Haranaki K. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity:role of glucose, insulin and macrophages. J Natl Can Inst 1985; 74: 1255-70.
55. Boichot E, Sannomia P, Escofier N, et al. Endotoxin induced acute lung injury in rats:role of insulin. Pulm Pharmacol Ther 1999; 12: 285-9.
56. Guidot DM, Hybertson BM, Kitlowski RP, Repine JE. Inhaled nitric oxide prevents IL-1 induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol 1996; 271: L225-31.
57. Nilsson L, Sara VR, Norberg A. Insulin like growth factor-1 stimulates the release of acetylecholine from rat cortical slices. Neurosci Letter 1988; 88: 221-6.
58. Xu Z, Tong Ceisenach JC. Acetylecholine stimulates the release of nitric oxide from rat spinal cord. Anaesthesiology 1996; 85: 107-12.
59. Borkman M, Stolien LH, Pan DA, et al. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993; 328: 238-42.
60. Somova L, Moodley K, Channa ML, Nadar A. Dose dependent effect of dietary fish oil(n-3)polyunsaturated fatty acids on invivo insulin sensitivity in rat. Methods Find Exp Clin Pharmacol 1999; 21: 275-80.
61. Huang YJ, Fang VS, Chou YC, Kwok CF, Ho LT. Amelioration of insulin resistance and hypertension in a fructose-rat model with fish oil supplementation. Metabolism 1997; 46: 1252-6.
62. Mori Y, Murakawa Y, Katoh S, et al. Influence of highly purified eicosapentaenoic acid ethyle ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat;a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism 1997; 46: 1458-63.
63. Nobukata H, Ishikawa T, Obata M, Shibutani Y. Longterm administration of highly purified eicosapentaenoic acid ethyle ester prevents diabetes and abnormalities of blood coagulation in maleWBN/kob rats. Metabolism 2000; 49: 912-7.
64. Ravelli AC, van der Meulen JH, Osmond C, Barker DJ, Bleker OP. Infant feeding and adult glucose tolerance, lipid profile, blood pressure and obesity. Arch Dis Child 2000; 82: 248-55.
65. Baur LA, O Conner J, Pan DA, Kriketos AD, Storlien LH. The fatty acid composition of skeletal muscle membrane phospholipid:its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 1998; 47: 106-12.
66. Singh RB, Rastogi SS, Rastogi V, et al. Blood pressure trends, plasma insulin levels, and risk factors in rural and urban elderly populations of North India. Coron Art Dis 1997; 8: 463-8.
67. Bhopal R. Epidemic of cardiovascular disease in south Asians. BMJ 2002; 324: 625.
68. Thomas GN, Tomlinson B, Chan JCN, Lee ZSK, Cockram CS, Critchley JAJH. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hyperten 2000; 13: 745-52.
69. Tettitt DJ, Foreman MR, Hanson RL, Knowler WC, Bennett PH. Longterm effects of intrauterine environment, birth weight and breast feeding in Pima Indians. Diab Care 1998; 21:(supple 2) B138-42.
70. Pettitt DJ, Forman MR, Hansen RL, Knowler WC, Bennet PH. Breast feeding and incidence of non-insulin diabetes mellitus in Pima Indians. Lancet 1997; 350: 166-71.
71. Pelikonova T, Kohout M, Valek J, Base J, Kazdova. Insulin secretion and insulin action related to serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38: 188-92.
72. Clifton PM, Nestel PJ. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 912-7.
73. Rivellese AA, Maffetone A, Lovine C, et al. Longterm effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 1996; 19: 1207-12.
74. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure:two cohorts after randomized trials. Lancet 2001; 357: 413-7.
75. Das UN. Can perinatal supplementation of long chain polyunsaturated fatty acids prevent hypertension in adult life? Hypertension 2002; 38: 16-7.
76. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction:Diet and Reinfarction Trial (DART). Lancet 1989; ii: 757-61.
77. Singh RB, Gal D, Niaz MA, et al. The effect of an IndoMediterranean diet on progression of coronary artery disease in high risk patients:the Indo-Mediterranean diet heart study. Lancet 2002; 360: 1455-61.
78. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of GISSI-prevenzione trial. Lancet 1999; 354: 447-55.
79. Carlson SE, Rhodes PG, Ferguson MG. DHA status of preterm infants at birth and following feeding with human milk and formula. Am J Clin Nutr 1985; 44: 798-804.
80. Cunnane SC, Francescutti V, Brenna T, Crawford MA. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoic acid accumulation than formula fed infants not consuming dietary dicosahexaenoate. Lipids 2000; 35: 105-10.
81. Bochm G, Borte M, Bohles HJ, et al. Docosahexaenoic and arachidonic acid content of serum and red cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long chain polyunsaturated fatty acids. Eur J Pediatr 1996; 155: 410-6.
82. Mattson MP, Camandola S. NF-kB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107: 247-53.
83. Weisinger HS, Armitage JA, Sinclair AJ, et al. Perinatal omega-3 deficiency affects blood pressure in later life. Nat Med 2001; 7: 258-60.
84. Scherezenmeir J, Jagla A. Milk and diabetes. J Am Coll Nutr 2000; 19: 176S-7.
85. Fall CHD, Barker DJP, Osmond C, et al. Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease. BMJ 1992; 304: 801-5.
86. Wijendran V, Bendel RB, Couch SC, et al. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids 2000; 35: 927-31.
87. Bisschop PH, de Metz J, Ackermans MT, et al. Substituting dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001; 73: 554-8.
88. Vessby B, Uusitupa M, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women:the KANWU study. Diabetologia 2001; 44: 312-6.
89. Hu FB, van Dam RM, Liu S. Diet and risk of type 2 diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44: 805-9.
90. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001; 73: 1019-23.
91. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischemic heart disease:a retrospective cohort study of 129, 290 births. Lancet 2001; 357: 2002-5.
92. Hubinett A, Cnattingius S, Ekborn A, et al. Birth weight, early environment, and genetics, a study of twins discordant for acute myocardial infarction. Lancet 2001; 357: 1997-100.
93. Poulter NR. Birth weights, maternal cardiovascular events and Barker, s hypothesis. Lancet 2001; 357: 1990-91.
94. Ozanne SE, Martensz ND, Petry CJ, Loizou CL, Hales CN. Maternal low protein diet in rats programs fatty acid desaturase activity in the offspring. Diabetologia 1998; 41: 1337-40.
95. Prado MD, Villalpando S, Elizondo A, et al. Contribution of dietary and newly formed arachidonic acid to human milk lipids in women eating a loe fat diet. Am J Clin Nutr 2001; 74: 242-6.
96. Koletzo B, Agostoni C, Carlson SE, et al. Long chain polyunsaturated fatty acids (LC-PUFAs) and perinatal development. Acta Paediatr 2001; 90: 460-5.
97. Barinaga M. No new -neurons dogma loses ground. Science 1998; 279: 2041-2.
98. Forsyth JS, Willats P, Agostoni C, Bissenden J, Casaer P, Boechm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood:follow up of a randomized, controlled trial. BMJ 2003; 326: 953-5.
99. Wang H, Yu M, Ochani M, et al. Nicotinic acetylecholine receptor alpha-7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
100. Andres Floto R, Smith KGC. The vagus nerve, macrophages and nicotine. Lancet 2003; 361: 1069-70.
101. Halberg F, Cornelissen G, Halberg J, et al. Circadian hyper-Amplitude-Tension, CHAT: a disease risk syndrome of anti aging medicine. JAAM 1998; 1: 239-59.
102. Singh RB, Pella D, Neki NS, Mestutake G, Niaz MA, Rastogi SS. Mechanism of acute myocardial infarction study. Bio Med Pharmacother 2004; 58(suppl): S111-55.
103. Vaidya AB, Bhatt MA. Chronobiology of ischaemic heart disease events: relevance of ancient insights in human lifestyle. J Assoc Physicians India 1999; 47: 629-30.
104. Mehta SR, Das S, Karloopia SD, Mathur P, Dham SK, Raghunathan D. The circadian pattern of ischaemic heart disease in Indian population. J Assoc Physicians India 1998; 46: 767-77.
105. Charaka Samhita (Charka, 600 BC) translated by Sharma PV, Chaukhambha Orientalia, Varanasi, Delhi 1981.
106. Pell SD, Allonzo CA. Acute myocardial infarction in a large industrial population. JAMA 1963; 185: 831-8.
107. Wennerblom B, LKurje L, Karsson T, Tygesen H, Vahisalo R, Hjamarson A. Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients. Int J Cardiol 2001; 79: 61-9.
108. Churisna SK, Ganelina IE. On the distribution of incidence of acute myocardial within a 24-hour period. Kardiologia 1975; 15: 115-8.
109. WHO International Study Group. Myocardial infarction community register, In: Public Health in Europe, Copenhagen, Regional office for Europe, 1976; 5: 1-232.
110. Watanabe Y, Conelissen G, Halberg F, Saito Y, Fukuda K, Otsuka K, Kikuchi T. Chronobiometric assessment of autogenic training effects upon blood pressure and heart rate. Perceptual and Motor Skill 1996; 83: 1395-410.
111. Tamura K, Kohna I, Saito Y, et al. Antihypertensive individualized therapeutic strategy. Diffesa Sociale 1991; 6: 109-24.
112. Manfredini R, Gallerani M, Portaluppi F, Salmi R, Fesim C. Chronobiological patterns of onset of acute cerebrovascular disease. Thromb Res 1997; 88: 451-63.
113. Cohen MC, Rohtla KM, Lavery CE, Muller IE, Mittleman MA. Metaanalysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79: 1512-6.
114. Singh RB, Cornelissen G, Siegelova J, Homolka P, Halberg F. About half weekly (circasemiceptan)pattern in blood pressure and heart rate in men women of India. Scr Med (Brno) 2002; 75: 125-8.
115. Kukreja RS, Datta BN, Chakravarti RN. Catechoamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 1981; 40: 291-8.
116. Cugini P, Letizia C, Searvo D. The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with circadian cycle of plasma renin and aldosterone. Chronobiologia 1988; 15: 229-32.
117. Veglio F, Pitrandice R, Ossola, M, Vignani A, Angili A. Circadian rhythm of the angiotensin coverting enzyme activity in serum of healthy adult subjects. Chronobiologia 1997; 14: 21-5.
118. Christensen IH, Gustenhoff P, Komp E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction. Br Med J 1996; 312: 677-8.
119. Christensen IH, Komp E, Aaroe I, et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997; 79: 1670-2.
120. Gudbjarnason S. Dynamics of n-3 fatty acids in phospholipids of heart muscle. J Intern Med 1989; 225(Suppl): 117-28.
121. Singh RB, Niaz MA, Sharma IP, Kumar R, Rastogi V, Moshiri M. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction. The Indian experiment of infarct survival. Cardiovasc Drug Ther 1997; 11: 485-91.
122. Singh RB, Wander GS, Rastogi A, et al. Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drug Ther 1998; 12: 347-53.
123. Pepe S, Bogdonor K, Hallaq H, Spurgeon H, Leaf A, Lakatta E. Omega-3 polyunsaturated fatty acids modulates dihydropyridine effects on L-type Ca-channels, cytosolic Ca and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci USA 1994; 91: 8832-6.
124. Chin JPF. Marine oils and cardiovascular reactivity. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 211-22.
125. Christensen JH, Christensen MS, Toft E, Dyerberg J, Schmidt EB. Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis 2001; 10: 57-61.
126. Christensen JH, Skou HA, Fog L, et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiograph. Circulation 2001; 103: 623-35.
127. Perini R, Milesi S, Fisher NM, Pendergast DR, Veicsteinas A. Heart rate variability during dynamic exercise in elderly males and females. Eur J Appl Physiol 2000; 82: 8-15.
128. Duru F, Chandinas R, Dziekan G, Goebbels U, Myers J, Dubach P. Effect of exercise training on heart rate variability in patients with new onset left ventricular dysfunction after myocardial infarction. Am Heart J 2000; 140: 157-61.
129. Bernardi L, Wdowczyk-Szule J, Vaenti C, Castoldi S, Passino C, Spadacini G, Sleight P. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol 2000; 35: 1462-9.
130. Garcia-Conzalez MA, Vazquez Seisdedos C, Pallas-Areny R. Variations in breathing patterns increase low frequency contents in HRV spectra. Physiol Meas 2000; 21: 417-23.
131. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Non selective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 2000; 36: 1612-8.
132. Kruger C, Landerer V, Zugck C, Ehmke H, Kubler W, Haass M. The bradycardic agent zatebrandine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc Res 2000; 45: 900-12.
133. Weydahl A, Conelissen G, Halberg F, Siegelova J, Kumagai Y, Otsuka K. Chronobiologic optimization of exercise physiology and practice guided by heart rate variability. Scr Med (BRNO) 1998; 71: 215-30.
134. Korkmaz ME, Muderrisoglu H, Ulucam, Ozin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol 2000; 86: 649-53.
135. Paolisso G, Manzella D, Rizzo MR, Ragno E, Barbieri M, Varricchio G, Varricchio M. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr 2000; 72: 723-30.
136. Singh JP, Larson MG, O'Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000; 86: 309-11.
137. Lanza GA, Giordano A, Pristipino C, et al. Relationship between myocardial 1231-metaiodobenzyl-guanidine scientigraphic uptake and heart rate variability in patients with syndrome X. Ital Heart J 2001; l: 221-5.
138. Paolisso G, Manzella D, Montano N, Gambradella A, Varricho M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 2000; 85: 1810-4.
139. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation 2000; 101: 1267-73.
140. Yee KM, Pringle SD, Struthers A. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol 2001; 37: 1800-7.
141. Aronson D, Burger AJ. Effect of beta blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol 2001; 6: 98-106.
142. Lin LY, Lin JL, Du CC, Lai LP, Tseng Yz, Huang SK. Reversal of deteriorated fractal behaviour of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. Cardiovasc Electrophysiol 2001; 12: 33-5.
143. Ulgen MS, Akdemir O, Toprak N. The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in the early period of acute myocardial infarction. Int J Cardiol 2001; 77: 255-62.
144. Lawrence JM, Stirling C, Reid J, Reckless JPD, Taylor GJ. Favorable effects of pioglitazones and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes. Diabetes Care 2004; 27: 41-6.
145. Schulze MB, Hu FB. Dietary approaches to prevent the metabolic syndrome. Diabetes Care 2004; 27: 613-4.
146. McKeown NM, Meigs JB, Liu S, Salzman E, Wilson PWF, Jacques P. Carbohydrate nutrition, insulin resistance and the prevalence of metabolic syndrome in the Framingham Offspring cohort. Diabetes Care 2004; 27: 538-46.
147. Liese AD, Roach AK, Sparks KC, Marquan L, Deguastino RB, Mayer-Davies EJ. Whole grain intake and insulin sensitivity:the insulin resistance Atherosclerosis Study. Am J Clin Nutr 2003; 78: 965-71.
148. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med 2004; 21: 208-13
149. Mohlig M, Boeing H, Spranger J, et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 1885-90.
150. Simopoulos AP. Is Insulin Resistance Influenced by Dietary Linoleic Acid and Trans Fatty Acids? Free Radic Biol Med 1994: 17; 367-72.
151. Singh RB, Cornelissen G, Kumar A, Bathina S, Halberg F. Larger Circadian Amplitude of Heart Rate Associated with Active Prayer in Hindu Indians in Asia. World Heart J 2009; 1: 219-22.
152. Mechirova V, Singh RB, De Meester F, Juneja L, Pella D. Protective effects of wild food whole grains against cardiovascular disease? World Heart J 2009; 1: 137-8.
153. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-61.
154. He K. Magnesium Intake and Incidence of Metabolic Syndrome Among Young Adults. Circulation 2006; 113(13): 1675-82.
155. Rumawas M. Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am J Clin Nutr 2009; 90: 1608-14.
156. American Heart Association Website: "Metabolic Syndrome" www.americanheart.org/presenter.jhtml?identifier=4756
157. Sawada T, Yokoi K. Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr 2010; 64: 331-3.
158. De Meester F. Progress in lipid nutrition: the Columbus Concept addressing chronic diseases. In: Simopoulos AP, De Meester F Eds. A Balanced Omega-6/Omega-3 Fatty Acid Ratio, Cholesterol and Coronary Heart Disease. World Review of Nutrition and Dietetics, (Simopoulos AP, series Ed). Basel: Karger; 2009. Vol. 100 pp. 110-121.